Horizons in Cancer Research. Volume 67

$290.00

Hiroto S. Watanabe (Editor)

Series: Horizons in Cancer Research
BISAC: MED062000

This book presents original results on the leading edge of cancer research. Chapter One reviews microRNAs as a novel diagnostic and predictive biomarker in human cancer. Chapter Two discusses the deregulated expression and function of S100 proteins in cancer cells. Chapter Three studies the current management of nasopharyngeal carcinoma and future directions in clinical research. Chapter Four examines the human papillomavirus vaccine. (Imprint: Nova Biomedical)

Table of Contents

Table of Contents

Preface

Chapter 1. miRNA as a Novel Diagnostic and Predictive Biomarker in Human Cancers
Vivek Kumar, Meghna Suhag and Manisha Sachan (Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, India, and others)

Chapter 2. The Deregulated Expression and Function of S100 Proteins in Cancer Cells
Ota Fuchs (Institute of Hematology and Blood Transfusion, Prague, Czech Republic)

Chapter 3. Recent Perspectives in the Management of Nasopharyngeal Carcinoma
Moncef Sellami, Sana Ennouri, Ines Ayadi, Nabil Toumi, Boutheina Hammami, Ilhem Charfeddine, Afef Khanfir, Mounir Frikha, Malek Mnejja and Abdelmonem Ghorbel (Department of otorhinolaryngology-Head and Neck Surgery, Habib Bourguiba University Hospital, Sfax, Tunisia, and others)

Chapter 4. The State-of-the-Art Therapeutic Human Papillomavirus Vaccine
Ciro Comparetto and Franco Borruto (Division of Obstetrics and Gynecology, City Hospital, Azienda USL Toscana Centro, Prato, Italy, and others)

Index

Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!